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Summary .  Calcium activated neutral proteinase 
(calpain) is an endopeptidase present in the central 
nervous system which degrades myelin proteins. To 
examine the role of calpain in demyelination associated 
with optic neuritis, immunocytochemical expression of 
calpain was evaluated in Lewis rats with experimental 
optic neuritis. Calpain expression was increased in 
activated microglia, infiltrating macrophages, activated 
T cells, and reactive astrocytes in experimental optic 
neuritis compared to controls. Calpain activity and 
translational expression were also examined by Western 
blotting studies measuring the extent of myelin protein 
degradation, calpain-specific fodrin proteolysis, axonal 
neurofilament degradation, and calpain proenzyme 
content. Results showed myelin associated glycoprotein 
and 68  kD neurofilament protein levels were 
significantly decreased while calpain translational 
expression and calpain-autolyzed fodrin levels were 
significantly increased in experimental optic neuritis 
compared to controls. Thus, increased activity and 
translational expression of calpain in optic neuritis may 
be integral to the pathogenesis of this disorder. 
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Introduction 
Optic nerve degeneration is one of the most common 
features of optic neuritis (ON) which leads to impaired 
vision and possible blindness. This condition is also 
recognized as one of the first manifestations of multiple 
sclerosis (MS) although not all patients with ON 
subsequently develop MS. Thus, subtle differences 
between these two degenerative diseases may exist. 
Although optic neuritis is thought to be a T cell mediated 
autoimmune disease like MS, the etiological factor(s) 
and pathophysiological mechanisms responsible for 
optic nerve degeneration remain poorly understood. 
Offprint requests to: Naren L. Banik, Ph.D, Department of Neurology, 
Medical University of South Carolina, 171 Ashley Ave., Charleston, S.C. 
29425, USA. Fax: (843) 792-8626. e-mail: baniknl@MUSC.edu 
Thus, detailed pathophysiological, biochemical and 
therapeutic s tudies  in animal models of ON are 
necessary for development of successful therapeutic 
protocols. 
The optic nerve is composed largely of myelinated 
axons and glial cells including astrocytes, oligodendro- 
cytes, and microglia. Axonal degeneration, myelin 
protein degradation, andlor death of myelin-forming 
oligodendrocytes and retina1 ganglion cel ls  may 
contribute to impaired vision associated with ON. The 
factors involved in myelin protein degradation have not 
been completely delineated, but proteases (including 
lysosomal and neutral proteinases) that degrade axon 
and myelin proteins have been implicated in de- 
myelinating diseases such as MS (Hallpike and Adams, 
1969; Smith, 1977; Allen, 1983; Banik, 1992). Calpain, 
a calcium-activated neutral proteinase is one such 
enzyme which has recently been shown to play a role in 
tissue degeneration associated with CNS trauma, MS, 
and experimental allergic encephalomyelitis (EAE), the 
corresponding MS animal model (Saatman et al., 1996; 
Banik et al., 1997; Kampfl et al., 1997; Shields and 
Banik, 1998a). The ubiquitous form of calpain exists as 
microcalpain (pcalpain) and millicalpain (mcalpain) 
isoforms which require pM and mM calcium levels, 
respectively, for activation. 
The mechanism of optic nerve degeneration in ON 
has been studied in EAE, an animal model of ON as 
well. The disease is induced in animals after sub- 
cutaneous injection of emulsified whole myelinl 
myelin proteins, [e.g., myelin basic protein (MBP)] and 
complete Freund's adjuvant with the onset of clinical 
symptoms at 10-12 days following administration. 
Earlier histopathological studies of optic nerves from 
animals with EAE revealed features also observed in MS 
such as  infiltration of inflammatory cells and 
degeneration of axons and myelin (Bullington and 
Waksman, 1958; VonSallman et al., 1967). Recent 
histopathologic and electron microscopic studies have 
demonstrated perivascular cuffing, degeneration, and 
phagocytosis of myelin in ON, an important feature of 
chronic experimental ON (Rao, 1981). While these 
studies clearly demonstrated cellular infiltration, gliosis 
and morphological changes, including ultrastructural 







